Develops and commercializes branded prescription products for the hospital acute care and gastroenterology markets.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. Key products include Acetadote for acetaminophen poisoning, Caldolor for pain and fever, Kristalose for constipation, Omeclamox-Pak for Helicobacter pylori infection, Vaprisol for hyponatremia, and Vibativ for serious bacterial infections. The company also develops RediTrex for arthritis and psoriasis, and is advancing ifetroban in clinical trials for various conditions including respiratory disease and muscular dystrophy.
Headquartered in Nashville, Tennessee, Cumberland Pharmaceuticals Inc. was founded in 1999. The company is dedicated to advancing therapeutic options through innovative drug development and strategic acquisitions in the pharmaceutical sector, focusing on improving patient outcomes globally.
Founded in 1999, Cumberland Pharmaceuticals Inc. specializes in acquiring, developing, and commercializing prescription products for hospital acute care, gastroenterology, rheumatology, and oncology. Key products include Acetadote, Caldolor, Kristalose, Omeclamox-Pak, Vaprisol, and Vibativ. The company is committed to advancing medical solutions through ongoing research and development, with a focus on enhancing treatment options for critical medical conditions worldwide.